These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10230895)

  • 1. A chromogenic substrate assay kit for factor XII: evaluation and use for the measurement of factor XII levels in cardiopulmonary bypass patients.
    Gallimore MJ; Jones DW; Wendel HP
    Thromb Res; 1999 Apr; 94(2):103-9. PubMed ID: 10230895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FXII levels, FXIIa-like activities and kallikrein activities in normal subjects and patients undergoing cardiac surgery.
    Wendel HP; Jones DW; Gallimore MJ
    Immunopharmacology; 1999 Dec; 45(1-3):141-4. PubMed ID: 10615003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An automated chromogenic peptide substrate assay for coagulation factor XII.
    Jones DW; Gallimore MJ; Winter M
    Blood Coagul Fibrinolysis; 1998 Mar; 9(2):183-7. PubMed ID: 9622217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in high molecular weight kininogen levels during and after cardiopulmonary bypass surgery measured using a chromogenic peptide substrate assay.
    Gallimore MJ; Jones DW; Winter M; Wendel HP
    Blood Coagul Fibrinolysis; 2002 Sep; 13(6):561-8. PubMed ID: 12192309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XII assay with the chromogenic substrate chromozym PK.
    Dick W; Cullmann W; Müller N; Adler K
    J Clin Chem Clin Biochem; 1981 Jun; 19(6):357-61. PubMed ID: 6168728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay for Hageman factor (factor XII) in human plasma by means of chromogenic substrate for plasma kallikrein.
    Egberg N; Overmark-Berggren I
    Thromb Res; 1983 Sep; 31(6):875-80. PubMed ID: 6557688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new assay for the determination of factor XII in plasma using a chromogenic substrate and a selective inhibitor of plasma kallikrein.
    Stürzebecher J; Svendsen L; Eichenberger R; Markwardt F
    Thromb Res; 1989 Sep; 55(6):709-15. PubMed ID: 2781533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XII determinations in the presence and absence of phospholipid antibodies.
    Gallimore MJ; Jones DW; Winter M
    Thromb Haemost; 1998 Jan; 79(1):87-90. PubMed ID: 9459329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microtitre chromogenic substrate assay for factor XII.
    Walshe KJ; Mackie IJ; Gallimore M; Machin SJ
    Thromb Res; 1987 Aug; 47(3):365-71. PubMed ID: 3629562
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogenic peptide substrate assays in patients with multiple trauma.
    Kierulf P; Aasen AO; Aune S; Godal HC; Ruud TE; Vaage J
    Acta Chir Scand Suppl; 1982; 509():69-72. PubMed ID: 6962622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct assay of factor XIIa in plasma with synthetic chromogenic substrates.
    Kluft C; Svendsen L; Los P
    Adv Exp Med Biol; 1983; 156():201-4. PubMed ID: 6190367
    [No Abstract]   [Full Text] [Related]  

  • 14. Factor XII Deficiency and Cardiopulmonary Bypass.
    Uppal V; Rosin M
    J Extra Corpor Technol; 2014 Sep; 46(3):254-7. PubMed ID: 26357792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications for cardiac surgery in patients with factor XII deficiency.
    Conaglen PJ; Akowuah E; Theodore S; Atkinson V
    Ann Thorac Surg; 2010 Feb; 89(2):625-6. PubMed ID: 20103363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass.
    Burman JF; Chung HI; Lane DA; Philippou H; Adami A; Lincoln JC
    Lancet; 1994 Oct; 344(8931):1192-3. PubMed ID: 7934541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.
    Gallimore MJ; Harris SL; Jones DW; Winter M
    Thromb Res; 2004; 114(2):91-6. PubMed ID: 15306150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of factor XII activity and granulocyte elastase release during cardiopulmonary bypass.
    Irvine L; Sundaram S; Courtney JM; Taggart DP; Wheatley DJ; Lowe GD
    ASAIO Trans; 1991; 37(4):569-71. PubMed ID: 1768490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary Bypass in a Patient with Factor XII Deficiency.
    Cronbaugh RD; Fuller LA; Miller SD; Richenbacher WE
    J Extra Corpor Technol; 2014 Sep; 46(3):251-3. PubMed ID: 26357791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.